2 Comments
User's avatar
Steve Cheung's avatar

Been looking forward to this. Thanks also for focussing on the dosing issue. I was among those whose initial takeaway was “don’t use tartrate in HFrEF” so this was helpful info.

I am still biased towards using a BB with direct HFrEF evidence, although I agree that this trial was tilted by design against tartrate. Fortunately there are a couple of options, although in Canada we do not have succinate.

Expand full comment
Cardiology Trials's avatar

Interesting that you don't have succinate. As you mentioned, several other reasonable options though

Expand full comment